Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: nVNS for the Prevention and Treatment of Primary Headache [NA]

View source ↗

Summary

Clinical trial evaluating non-invasive vagus nerve stimulation for prevention and treatment of primary headache disorders, including migraine in adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • nVNS (non-invasive vagus nerve stimulation)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Primary Headache, Migraine in Adolescence | NA | Status: RECRUITING